Publication | Closed Access
Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study
16
Citations
32
References
2020
Year
Genpe StudyGynecologyPathologyCandidate BiomarkerMedicineHellp SyndromePreeclampsiaMolecular Medicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1